Recent News

• 06.08.2026 - Capricor Therapeutics to Present at Upcoming Investor Conferences
• 06.08.2026 - Capricor Therapeutics to Present at Upcoming Investor Conferences
• 05.29.2026 - Capricor Therapeutics Expands Commercial Leadership Team
• 05.12.2026 - Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
• 05.12.2026 - Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
• 05.07.2026 - Capricor Therapeutics Takes Legal Action to Protect Patient Access to Deramiocel for Duchenne Muscular Dystrophy
• 05.04.2026 - Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12
• 05.04.2026 - Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Recent Filings

• 06.08.2026 - 8-K Current report
• 05.28.2026 - 3 Initial statement of beneficial ownership of securities
• 05.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2026 - 144/A Report of proposed sale of securities
• 05.19.2026 - 144 Report of proposed sale of securities
• 05.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.14.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.12.2026 - EX-99.1 EX-99.1
• 05.12.2026 - 8-K Current report